🔗 You are viewing a shared knowledge page for: Scfe

Scfe

Educational clinical summary of Scfe for doctors and students: definition, workup, management, and key caveats. Not a substitute for guidelines.

Maintained by Dr. Vivek Karn Review process: editorial policy

Disclaimer: This information is intended for educational purposes and should not be considered medical advice. Clinical decisions must be made by qualified healthcare professionals based on individual patient circumstances, current evidence, and professional judgment. Always consult with a physician or other healthcare provider for diagnosis and treatment of any medical condition.

Scfe (Slipped Capital Femoral Epiphysis)

Overview

  • Definition: Slipped Capital Femoral Epiphysis (SCFE) is a condition characterized by the displacement of the femoral head (epiphysis) relative to the femoral neck through the physeal (growth) plate. The epiphysis displaces inferomedially and posteriorly, while the femoral neck displaces anterolaterally. It is considered a Salter-Harris Type I fracture of the proximal femoral physis.
  • Epidemiology:
    • Incidence: Ranges from 0.3 to 24.5 cases per 100,000 children annually, with significant geographic variation.
    • Age: Typically affects adolescents during periods of rapid growth. Peak incidence is 10-16 years for boys and 9-14 years for girls.
    • Sex: Boys are affected 2-3 times more often than girls.
    • Laterality: Unilateral in 60-80% of cases at presentation, but bilateral involvement occurs in 20-60% of cases, either synchronously or asynchronously. The risk of contralateral slip is highest in the first 12-18 months after initial diagnosis, especially in younger patients or those with endocrine comorbidities.
    • Risk Factors: Obesity is the most significant risk factor.
  • Classification:
    • By Stability (Crucial for Prognosis and Management):
      • Stable SCFE: The patient is able to bear weight on the affected leg, with or without crutches. Pain is usually chronic or intermittent. This accounts for ~90% of cases. Lower risk of avascular necrosis (AVN).
      • Unstable SCFE: The patient is unable to bear weight, even with crutches, due to severe pain. Often associated with acute trauma and severe displacement. Higher risk of AVN (up to 47%) and other serious complications.
    • By Duration of Symptoms:
      • Acute SCFE: Symptoms present for less than 3 weeks. Often associated with trauma, severe pain, and inability to bear weight.
      • Chronic SCFE: Symptoms present for more than 3 weeks (most common, ~85%). Patients often present with a limp and vague hip/thigh/knee pain.
      • Acute-on-chronic SCFE: Pre-existing chronic symptoms with an acute exacerbation (e.g., due to minor trauma) causing inability to bear weight.

Pathophysiology

  • Mechanism: SCFE is multifactorial, involving both mechanical and biological factors that weaken the physis:
    • Mechanical Stress: Increased shear stress across the physis, often exacerbated by obesity. The physis is oriented obliquely to the weight-bearing axis, making it susceptible to shear forces.
    • Physeal Weakness:
      • Growth Plate Hypertrophy: During rapid growth spurts, the physis becomes wider and weaker due to increased hypertrophy and decreased strength of the zone of provisional calcification.
      • Endocrine Factors: Hormonal imbalances (e.g., hypothyroidism, growth hormone deficiency, renal osteodystrophy) can impair chondrocyte maturation and physeal stability.
      • Perichondral Ring: Weakness or failure of the perichondral ring (Ranvier's groove), which normally stabilizes the physis, contributes to slippage.
  • Risk Factors:
    • Obesity: Most prominent risk factor, accounting for 60-80% of cases. Increased body mass index (BMI) significantly increases mechanical stress on the physis.
    • Rapid Growth Spurts: Occurs during puberty, when the physis is undergoing rapid changes and potentially weakened.
    • Endocrine Disorders:
      • Hypothyroidism (most common endocrine association)
      • Growth Hormone (GH) deficiency or GH treatment (iatrogenic SCFE due to rapid growth)
      • Panhypopituitarism
      • Renal osteodystrophy (secondary hyperparathyroidism leading to osteopenia)
      • Adrenal disorders
    • Mechanical Factors: Retroversion of the femoral neck, increased hip adduction and external rotation.
    • Previous Radiation Therapy: Especially to the hip region.
    • Genetic Predisposition: Familial predisposition noted in some cases.
  • Protective Factors:
    • Maintaining a healthy weight.
    • Appropriate management of underlying endocrine disorders.
    • Early diagnosis and treatment to prevent progression of slip.

Clinical Presentation

Signs and Symptoms

  • Cardinal Features:
    • Pain: Variable. Can be hip, groin, thigh, or knee pain. Knee pain is a common referred pain and a diagnostic pitfall.
    • Limp: Often the first noticeable symptom, typically an antalgic or Trendelenburg gait.
    • Decreased Range of Motion: Particularly hip internal rotation, abduction, and flexion.
  • Early Signs:
    • Vague, intermittent knee or thigh pain.
    • Subtle, often non-specific limp, sometimes worse after activity.
    • Fatigue during walking or sports.
  • Advanced Signs:
    • Severe hip pain, often exacerbated by activity.
    • Inability to bear weight (unstable SCFE).
    • Noticeable limb shortening and external rotation of the affected leg.
    • Severe limp, often with a Trendelenburg component.
  • Atypical Presentations:
    • Isolated knee pain (up to 50% of cases).
    • Bilateral simultaneous presentation (less common, but higher in endocrine-related SCFE).
    • Younger age (<10 years) or older age (>16 years) suggests an underlying systemic disorder.
    • Absence of obesity.

Physical Examination

  • Inspection:
    • Gait: Antalgic limp, Trendelenburg gait.
    • Posture: Affected limb may be held in external rotation and slight abduction, especially in severe slips.
    • Leg Length Discrepancy: May be present in severe or chronic slips due to posterior displacement and shortening.
  • Palpation:
    • No specific palpable findings, but mild tenderness may be present in the groin or proximal thigh.
  • Special Tests:
    • Range of Motion (ROM):
      • Restricted Internal Rotation: Most consistent finding. Often severely limited or absent.
      • Restricted Abduction: Often limited.
      • Obligate External Rotation with Flexion: As the hip is passively flexed, the leg automatically goes into external rotation. This is a highly specific sign due to the posterior displacement of the femoral head relative to the neck.
    • Trendelenburg Test: May be positive, indicating abductor weakness.
    • Motor/Sensory: Usually normal unless there is a rare neurovascular complication.

Diagnostic Approach

History Taking

  • Key Questions:
    • Pain Characteristics: Onset (acute vs. insidious), duration, location (hip, groin, thigh, knee), character (dull ache, sharp pain), aggravating/alleviating factors.
    • Limp: Onset, progression, consistency.
    • Activity Level: Any recent increase in physical activity or minor trauma.
    • Growth History: Recent growth spurt, weight gain.
    • Medical History: History of endocrine disorders (hypothyroidism, GHD, renal disease), previous radiation therapy.
    • Family History: Any family members with SCFE or endocrine conditions.
    • Bilateral Symptoms: Always ask about symptoms in the contralateral hip/knee.
  • Red Flags:
    • Inability to bear weight (unstable SCFE – surgical emergency).
    • Acute onset of severe hip pain after minor trauma.
    • Systemic symptoms (fatigue, cold intolerance, weight changes) suggestive of an underlying endocrine disorder.
    • Younger age (<10 years) or older age (>16 years).

Laboratory Tests

  • First-Line: No specific laboratory tests are diagnostic for SCFE itself. However, they are crucial for identifying underlying risk factors.
    • Complete Blood Count (CBC) and Erythrocyte Sedimentation Rate (ESR)/C-reactive protein (CRP) to rule out infection or inflammatory conditions (e.g., septic arthritis, transient synovitis).
  • Confirmatory: N/A for the mechanical diagnosis of SCFE.
  • Monitoring: If an underlying endocrine etiology is suspected based on history or atypical presentation:
    • Thyroid Function Tests: Thyroid Stimulating Hormone (TSH), Free T4.
    • Growth Hormone Axis: IGF-1 (Insulin-like Growth Factor 1) if GH deficiency is suspected.
    • Renal Function Tests: BUN, Creatinine, Electrolytes, Calcium, Phosphorus, Alkaline Phosphatase (ALP) for renal osteodystrophy.
    • Bone Age: To assess skeletal maturity.

Imaging

  • Recommended: Bilateral hip radiographs are the cornerstone of diagnosis. Always include the contralateral hip as a reference and to check for synchronous slip.
    • Anteroposterior (AP) View:
      • Klein's Line (Southwick's Line): A line drawn along the superior border of the femoral neck. In a normal hip, this line should intersect a portion of the epiphysis. In SCFE, the line either fails to intersect the epiphysis or intersects a smaller portion, indicating posterior and inferior displacement.
      • Steel's Sign: Double density of the femoral neck due to posterior displacement of the epiphysis.
      • Widening of the physis.
      • Decreased epiphyseal height.
    • Frog-leg Lateral View: Crucial for diagnosis, as the slip is primarily posterior and may be subtle or missed on AP views alone. The best view to visualize the posterior displacement.
      • Klein's Line is also useful here, showing the posterior displacement.
      • Metaphyseal Blanching: Increased density (or "blanching") in the metaphyseal area adjacent to the physis due to overlap of the posteriorly displaced epiphysis.
  • Advanced:
    • Magnetic Resonance Imaging (MRI):
      • Can detect pre-slip changes (physeal edema, widening) before radiographic changes are evident, especially useful for contralateral hip evaluation.
      • Useful for differentiating SCFE from other conditions like transient synovitis, osteomyelitis, or AVN.
      • Can assess the extent of physeal injury and articular cartilage status.
    • Computed Tomography (CT):
      • Less commonly used for primary diagnosis.
      • Can be helpful for detailed 3D assessment of slip severity and morphology, particularly for surgical planning of severe or chronic slips requiring osteotomies.

Management

Acute Management

  • Immediate:
    • Strict Non-Weight Bearing: Crucial to prevent further slippage and reduce the risk of AVN. Patients should be immediately placed on crutches or a wheelchair.
    • Bed Rest: For unstable slips, immediate bed rest is necessary.
    • Analgesia: Administer pain medication as needed.
    • Urgent Orthopedic Consultation: SCFE is an orthopedic emergency, especially unstable slips.
  • Stabilization:
    • Minimize any motion of the affected hip. Avoid manipulation or closed reduction attempts as they significantly increase the risk of AVN.
    • Prepare for surgical stabilization as soon as possible.
  • Emergency:
    • Unstable SCFE: Requires immediate admission, strict non-weight bearing, and urgent surgical stabilization (usually within 24 hours) to prevent further displacement and reduce the risk of avascular necrosis (AVN).

Chronic Management

  • Pharmacological:
    • Pain management: NSAIDs for mild-moderate pain. Opioids may be needed short-term for severe pain.
    • Address underlying endocrine disorders (e.g., thyroid hormone replacement for hypothyroidism).
  • Non-pharmacological:
    • Activity Restriction: Continued non-weight bearing or limited weight bearing post-surgery until healing is confirmed. Gradual return to activities.
    • Weight Management: Crucial for obese patients to reduce mechanical stress and risk of contralateral slip.
    • Physical Therapy: Post-operative rehabilitation to restore range of motion, strength, and normalize gait.
  • Monitoring:
    • Clinical Follow-up: Regular follow-up appointments to monitor for pain, limp, and range of motion.
    • Radiographic Follow-up: AP and lateral hip radiographs every 3-6 months until physeal closure to monitor for slip progression, screw penetration, and especially for contralateral SCFE. Follow-up for at least 18 months, or until the contralateral physis closes, if prophylactic pinning was not performed.

Treatment Algorithms

  • First-Line:
    • In Situ Screw Fixation: The gold standard for stable SCFE. A single cannulated screw (or sometimes two, depending on surgeon preference and slip severity) is inserted across the physis to prevent further slippage and promote physeal closure. This minimally invasive procedure is safe and effective. Reduction is generally avoided in stable slips to prevent AVN.
  • Second-Line:
    • For Unstable SCFE: Immediate in situ screw fixation. Gentle, cautious traction may be considered pre-operatively, but vigorous reduction maneuvers are contraindicated due to the high risk of AVN.
    • For Severe Chronic Slips (often >60 degrees of slip):
      • Modified Dunn Procedure / Surgical Hip Dislocation: A more complex surgical procedure involving osteotomy of the femoral neck and repositioning of the femoral head. Aims to achieve anatomic reduction and prevent femoroacetabular impingement (FAI). Associated with higher risks, including AVN, but can lead to better long-term functional outcomes in carefully selected severe cases.
      • Cuneiform Osteotomy (e.g., Southwick osteotomy): Osteotomy through the proximal femur to correct the deformity. Done below the physis.
  • Refractory Cases:
    • Complication Management: Management of AVN, chondrolysis, or symptomatic FAI. May involve further osteotomies, core decompression (for early AVN), or ultimately total hip arthroplasty (THA) in adulthood.
    • Contralateral Prophylactic Pinning: Highly controversial, but considered in high-risk patients (e.g., those with endocrine disorders, younger age, or severe initial slip) to prevent contralateral SCFE, as the risk is significant. Advantages include preventing a second major event, disadvantages include potential complications from the surgery itself.

Complications

  • Common:
    • Contralateral SCFE: Occurs in 20-60% of patients, often within 18 months of the initial slip. Risk factors include obesity, endocrine disorders, and younger age.
    • Femoroacetabular Impingement (FAI): Common sequela of SCFE, even after fixation, due to residual deformity of the femoral head-neck junction. Can lead to pain and early osteoarthritis.
    • Chondrolysis: Acute loss of articular cartilage, leading to severe pain, stiffness, and rapid onset of osteoarthritis. Risk factors include multiple drill passes, screw penetration into the joint, and infection.
  • Serious:
    • Avascular Necrosis (AVN) of the Femoral Head: The most devastating complication, occurring due to disruption of the blood supply to the femoral head. Much more common in unstable SCFE (up to 47%) or with aggressive reduction maneuvers. Can lead to collapse of the femoral head and severe osteoarthritis.
    • Nonunion: Failure of the physis to fuse after fixation, leading to continued instability.
    • Infection: Surgical site infection (rare).
  • Long-term:
    • Early Onset Osteoarthritis: Due to residual deformity, FAI, chondrolysis, or AVN. Many patients will require total hip arthroplasty in middle age.
    • Chronic Pain and Limp: Persistent symptoms despite treatment.
    • Limb Length Discrepancy: Due to growth arrest or deformity.
    • Limited Range of Motion: Especially internal rotation and abduction.

Prognosis

  • Factors Affecting Outcome:
    • Stability of the Slip: Stable slips have a much better prognosis with lower rates of AVN. Unstable slips have significantly higher rates of AVN and worse overall outcomes.
    • Degree of Slip: Greater slip severity is associated with higher rates of FAI, requiring more complex corrective surgery, and potentially worse long-term function.
    • Promptness of Diagnosis and Treatment: Early diagnosis and timely in situ fixation improve outcomes and prevent progression.
    • Presence of Complications: Development of AVN or chondrolysis significantly worsens prognosis, leading to severe pain, disability, and early osteoarthritis.
    • Underlying Endocrine Disorders: Patients with endocrine disorders may have a higher risk of bilateral slips and slower healing.
  • Survival: SCFE itself is not life-threatening. However, it is associated with significant long-term morbidity and a reduction in quality of life.
  • Quality of Life: Patients may experience chronic pain, limitations in physical activity, and need for further surgical interventions throughout their life (e.g., for FAI or THA). Long-term studies show that many patients will develop symptomatic osteoarthritis requiring intervention by their 50s.

Prevention

  • Primary:
    • Weight Management: Counseling and intervention for childhood obesity, as it is the most significant modifiable risk factor.
    • Early Recognition and Management of Endocrine Disorders: Screening and appropriate treatment of conditions like hypothyroidism and growth hormone deficiency can reduce physeal weakness.
  • Secondary:
    • High Index of Suspicion: Clinicians should maintain a high index of suspicion for SCFE in any adolescent presenting with hip, thigh, or knee pain, especially if obese.
    • Appropriate Imaging: Always obtain AP and frog-leg lateral radiographs of both hips when SCFE is suspected. Do not rely solely on AP views or knee radiographs.
    • Thorough Physical Examination: Pay close attention to hip range of motion, particularly internal rotation and the obligate external rotation with flexion sign.
  • Tertiary:
    • Prompt Surgical Stabilization: Immediate non-weight bearing and urgent in situ fixation to prevent further slippage, minimize risk of AVN, and reduce long-term complications.
    • Contralateral Prophylactic Pinning: Consideration in high-risk patients (e.g., significant endocrine abnormalities, younger age) to prevent a second SCFE, which carries its own morbidity. This remains a debated topic.
    • Long-term Monitoring: Regular clinical and radiographic follow-up until physeal closure to monitor for contralateral slip, screw complications, and development of FAI or AVN.

Special Populations

  • Pediatric: SCFE is inherently a condition of adolescence.
    • Younger Patients (<10 years): Atypical age; significantly higher likelihood of an underlying endocrine or systemic disorder (e.g., hypothyroidism, renal osteodystrophy). A thorough endocrine workup is essential. These patients also have a higher risk of bilateral involvement.
    • Older Patients (>16 years): Less common, but can occur if physes remain open.
  • Geriatric: Not applicable (physes closed).
  • Pregnancy: Not applicable.
  • Comorbidities:
    • Obesity: The most common comorbidity. Requires counseling and long-term management to reduce overall health risks and potentially the risk of contralateral slip.
    • Endocrine Disorders: Hypothyroidism, growth hormone deficiency, renal osteodystrophy. These require specific medical management concurrent with orthopedic care. Their presence often increases the risk of bilateral SCFE and may influence the decision for prophylactic contralateral pinning.

Clinical Pearls

  • Diagnostic:
    • "Hip pain until proven otherwise" in an adolescent with knee or thigh pain. Always examine the hip.
    • Always get a frog-leg lateral view of both hips; AP views alone are insufficient and can miss up to 50% of slips.
    • The "obligate external rotation with flexion" sign is highly suggestive of SCFE.
    • Beware of the obese adolescent male presenting with a limp and vague pain.
  • Treatment:
    • Immediate non-weight bearing is paramount once SCFE is suspected.
    • Avoid aggressive reduction attempts for unstable slips, as this significantly increases the risk of AVN.
    • In situ screw fixation is the standard for stable slips. The goal is to stabilize the physis and prevent further displacement, not necessarily to achieve anatomical reduction.
    • Consider prophylactic pinning of the contralateral hip in high-risk patients, though it remains controversial.
  • Pitfalls:
    • Misdiagnosis: Often mistaken for knee pathology (e.g., Osgood-Schlatter disease, patellofemoral pain) due to referred pain, leading to delayed diagnosis.
    • Inadequate Imaging: Failing to obtain lateral hip views or imaging the contralateral hip.
    • Delayed Treatment: Prolonged weight-bearing on an unstable or unrecognized slip can lead to severe displacement and AVN.
    • Aggressive Reduction: Attempting closed reduction for unstable slips significantly increases the risk of AVN.

Recent Updates

  • Guidelines:
    • Current guidelines continue to emphasize urgent in situ screw fixation for stable SCFE and immediate stabilization for unstable SCFE.
    • Growing consensus that severe chronic slips benefit from anatomical reduction via surgical hip dislocation and osteotomy (e.g., modified Dunn procedure) to prevent FAI and improve long-term outcomes, though this is a complex procedure with higher risks.
  • Evidence:
    • Long-term studies continue to highlight the high incidence of FAI and early osteoarthritis following SCFE, even after successful fixation, underscoring the importance of preventing residual deformity.
    • Research on factors influencing contralateral SCFE continues, aiming to better identify candidates for prophylactic pinning.
    • Advancements in surgical techniques for severe slips aim to minimize complications while achieving better anatomical correction.
  • Controversies:
    • Prophylactic contralateral pinning: Ongoing debate regarding the risk-benefit ratio. Some argue it prevents future surgery and morbidity, others highlight the potential for complications of a prophylactic procedure.
    • Management of severe slips: The optimal timing and type of corrective osteotomy (e.g., modified Dunn vs. less invasive approaches) remains an area of active research and surgeon preference.
    • Role of MRI: Its routine use for screening contralateral hips or detecting pre-slip changes is being explored.

Key References

  • Guidelines:
    • American Academy of Orthopaedic Surgeons (AAOS) Clinical Practice Guidelines for Slipped Capital Femoral Epiphysis.
    • Pediatric Orthopaedic Society of North America (POSNA) guidelines and consensus statements on SCFE.
  • Studies:
    • Hofmann, A., & Caine, B. (2018). Slipped Capital Femoral Epiphysis. Journal of the American Academy of Orthopaedic Surgeons, 26(18), e388-e397.
    • Loder, R. T., & Skopelja, E. N. (2011). The Epidemiology and Demographics of Slipped Capital Femoral Epiphysis. ISRN Orthopedics, 2011, 486048.
    • Ganger, R., et al. (2020). Management of Slipped Capital Femoral Epiphysis. Journal of Clinical Medicine, 9(12), 4057.
  • Reviews:
    • Staheli, L. T. (2014). Fundamentals of Pediatric Orthopedics. Lippincott Williams & Wilkins.
    • Green, N. E., & Swiontkowski, M. F. (2019). Skeletal Trauma in Children. Elsevier.